A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology

Pisa, M; Watson, JL; Spencer, JI; Niblett, G; Mahjoub, Y; Lockhart, A; Yates, RL; Yee, SA; Hadley, G; Ruiz, J; Esiri, MM; Kessler, B; Fischer, R; DeLuca, GC

Journal article

A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology

Abstract:: Multiple sclerosis (MS) is unsurpassed for its clinical and pathological hetherogeneity, but the biological determinants of this variability are unknown. HLA‐DRB1*15, the main genetic risk factor for MS, influences the severity and distribution of MS pathology. This study set out to unravel the molecular determinants of the heterogeneity of MS pathology in relation to HLA‐DRB1*15 status. Shotgun proteomics from a discovery cohort of MS spinal cord samples segregated by HLA‐DRB*15 status revealed overexpression of the extracellular matrix (ECM) proteins, biglycan, decorin, and prolargin in HLA‐DRB*15‐positive cases, adding to established literature on a role of ECM proteins in MS pathology that has heretofore lacked systematic pathological validation. These findings informed a neuropathological characterisation of these proteins in a large autopsy cohort of 41 MS cases (18 HLA‐DRB1*15‐positive and 23 HLA‐DRB1*15‐negative), and seven non‐neurological controls on motor cortical, cervical and lumbar spinal cord tissue. Biglycan and decorin demonstrate a striking perivascular expression pattern in controls that is reduced in MS (−36.5%, p = 0.036 and − 24.7%, p = 0.039; respectively) in lesional and non‐lesional areas. A concomitant increase in diffuse parenchymal accumulation of biglycan and decorin is seen in MS (p = 0.015 and p = 0.001, respectively), particularly in HLA‐DRB1*15‐positive cases (p = 0.007 and p = 0.046, respectively). Prolargin shows a faint parenchymal pattern in controls that is markedly increased in MS cases where a perivascular deposition pattern is observed (motor cortex +97.5%, p = 0.001; cervical cord +49.1%, p = 0.016). Our findings point to ECM proteins and the vascular interface playing a central role in MS pathology within and outside the plaque area. As ECM proteins are known potent pro‐inflammatory molecules, their parenchymal accumulation may contribute to disease severity. This study brings to light novel factors that may contribute to the heterogeneity of the topographical variation of MS pathology.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Pisa, M., Watson, J. L., Spencer, J. I., Niblett, G., Mahjoub, Y., Lockhart, A., Yates, R. L., Yee, S. A., Hadley, G., Ruiz, J., Esiri, M. M., Kessler, B., Fischer, R., & DeLuca, G. C. (2024). A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology. Brain Pathology.

MLA Style

Pisa, M., et al. “A Role for Vessel‐Associated Extracellular Matrix Proteins in Multiple Sclerosis Pathology.” Brain Pathology, Wiley Open Access, 2024.

Chicago Style

Pisa, M, JL Watson, JI Spencer, G Niblett, Y Mahjoub, A Lockhart, RL Yates, et al. 2024. “A Role for Vessel‐Associated Extracellular Matrix Proteins in Multiple Sclerosis Pathology.” Brain Pathology.
Share
Print